Name:
Lead Nitrate Reagent ACS (Crystals)
Synonym:
Lead (II) Nitrate; Lead Dinitrate; Nitric Acid Lead (II) Salt
CAS:
10099-74-8
Section 1 - Chemical Product
MSDS Name:Lead Nitrate Reagent ACS (Crystals)
Synonym:Lead (II) Nitrate; Lead Dinitrate; Nitric Acid Lead (II) Salt
Synonym:Lead (II) Nitrate; Lead Dinitrate; Nitric Acid Lead (II) Salt
Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
| CAS# | Chemical Name | emsds | EINECS# |
| 10099-74-8 | Lead Nitrate | >99 | 233-245-9 |
| Hazard Symbols: T Risk Phrases: 20/22 33 61 62 |
Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation and if swallowed. Danger of cumulative effects. May cause harm to the unborn child. Possible risk of impaired fertility.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. May cause effects similar to those for inhalation exposure.
Inhalation:
May cause methemoglobinemia, cyanosis, convulsions, tachycardia, dyspnea (labored breathing), and death. May cause adverse central nervous system effects including headache, convulsions, and possible death. May cause kidney damage. May cause anemia.
Chronic:
Chronic inhalation and ingestion may cause effects similar to those of acute inhalation and ingestion. Prolonged or repeated exposure may cause adverse reproductive effects. May cause liver and kidney damage. Prolonged exposure may cause anemia and methemoglobinemia, characterized by dizziness, drowsiness, headache, breath shortness, cyanosis (bluish skin due to deficient oxygenation of the blood), rapid heart rate and chocolate-brown colored blood. Chronic exposure to lead may result in plumbism which is characterized by lead line in gum, headache, muscle weakness, mental changes.
Harmful by inhalation and if swallowed. Danger of cumulative effects. May cause harm to the unborn child. Possible risk of impaired fertility.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. May cause effects similar to those for inhalation exposure.
Inhalation:
May cause methemoglobinemia, cyanosis, convulsions, tachycardia, dyspnea (labored breathing), and death. May cause adverse central nervous system effects including headache, convulsions, and possible death. May cause kidney damage. May cause anemia.
Chronic:
Chronic inhalation and ingestion may cause effects similar to those of acute inhalation and ingestion. Prolonged or repeated exposure may cause adverse reproductive effects. May cause liver and kidney damage. Prolonged exposure may cause anemia and methemoglobinemia, characterized by dizziness, drowsiness, headache, breath shortness, cyanosis (bluish skin due to deficient oxygenation of the blood), rapid heart rate and chocolate-brown colored blood. Chronic exposure to lead may result in plumbism which is characterized by lead line in gum, headache, muscle weakness, mental changes.
Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid. Flush skin with plenty of soap and water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical aid immediately.
Inhalation:
Remove from exposure to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Get medical aid.
Notes to Physician:
Antidote: The use of Calcium disodium EDTA as a chelating agent should be determined by qualified medical personnel. The use of d-Penicillamine as a chelating agent should be determined by qualified medical personnel. The use of Dimercaprol or BAL (British Anti-Lewisite) as a chelating agent should be determined by qualified medical personnel.
Skin:
Get medical aid. Flush skin with plenty of soap and water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical aid immediately.
Inhalation:
Remove from exposure to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Get medical aid.
Notes to Physician:
Antidote: The use of Calcium disodium EDTA as a chelating agent should be determined by qualified medical personnel. The use of d-Penicillamine as a chelating agent should be determined by qualified medical personnel. The use of Dimercaprol or BAL (British Anti-Lewisite) as a chelating agent should be determined by qualified medical personnel.
Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Combustion generates toxic fumes. Oxidizer. Greatly increases the burning rate of combustible materials.
Extinguishing Media:
Use water only!
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Combustion generates toxic fumes. Oxidizer. Greatly increases the burning rate of combustible materials.
Extinguishing Media:
Use water only!
Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use only in a well-ventilated area. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Keep away from clothing and other combustible materials.
Storage:
Do not store near combustible materials. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use only in a well-ventilated area. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Keep away from clothing and other combustible materials.
Storage:
Do not store near combustible materials. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHAs eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29CFR 1910.134 or European Standard EN 149. Always use a NIOSH or European Standard EN 149 approved respirator when necessary.
Use adequate ventilation to keep airborne concentrations low.
Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHAs eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29CFR 1910.134 or European Standard EN 149. Always use a NIOSH or European Standard EN 149 approved respirator when necessary.
Section 9 - PHYSICAL AND CHEMICAL PROPERTIES
Physical State: Solid
Appearance: white
Odor: None reported.
pH: Not available.
Vapor Pressure: Negligible.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 470 deg C dec
Autoignition Temperature: Not available.
Flash Point: 290 deg C ( 554.00 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: 290 deg C
Solubility in water: 1g/2.5l absolute alcohol, 1g/75ml methan
Specific Gravity/Density: 4.5300g/cm3
Molecular Formula: PbN2O6
Molecular Weight: 331.20
Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures. Decomposes when heated.
Conditions to Avoid:
Incompatible materials, combustible materials, temperatures above 200C.
Incompatibilities with Other Materials:
Forms an explosive compound with: ammonium thiocyanate, potassium acetate, or lead hypophosphite. Other incompatibles include: aluminum, alkyl esters, carbon, hydroxylamine, phosphorus, phosphinates, sulfur, tin chloride.
Hazardous Decomposition Products:
Nitrogen oxides, lead/lead oxides.
Hazardous Polymerization: Has not been reported.
Stable under normal temperatures and pressures. Decomposes when heated.
Conditions to Avoid:
Incompatible materials, combustible materials, temperatures above 200C.
Incompatibilities with Other Materials:
Forms an explosive compound with: ammonium thiocyanate, potassium acetate, or lead hypophosphite. Other incompatibles include: aluminum, alkyl esters, carbon, hydroxylamine, phosphorus, phosphinates, sulfur, tin chloride.
Hazardous Decomposition Products:
Nitrogen oxides, lead/lead oxides.
Hazardous Polymerization: Has not been reported.
Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 10099-74-8: OG2100000 LD50/LC50:
Not available.
Carcinogenicity:
Lead Nitrate - ACGIH: A3 - Animal Carcinogen (as Pb) (listed as ** undefined **) California: carcinogen; initial date 10/1/92 (listed as ** undefined * OSHA: Possible select carcinogen (listed as ** undefined **).
IARC: Group 2B carcinogen (listed as ** undefined **).
Other:
See actual entry in RTECS for complete information.
CAS# 10099-74-8: OG2100000 LD50/LC50:
Not available.
Carcinogenicity:
Lead Nitrate - ACGIH: A3 - Animal Carcinogen (as Pb) (listed as ** undefined **) California: carcinogen; initial date 10/1/92 (listed as ** undefined * OSHA: Possible select carcinogen (listed as ** undefined **).
IARC: Group 2B carcinogen (listed as ** undefined **).
Other:
See actual entry in RTECS for complete information.
Section 12 - ECOLOGICAL INFORMATION
Other No information available.
Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.
Section 14 - TRANSPORT INFORMATION
IATA
Shipping Name: LEAD NITRATE
Hazard Class: 5.1
UN Number: 1469
Packing Group: II
IMO
Shipping Name: LEAD NITRATE
Hazard Class: 5.1
UN Number: 1469
Packing Group: II
RID/ADR
Shipping Name: LEAD NITRATE
Dangerous Goods Code: 5.1(29B)
UN Number: 1469
Section 15 - REGULATORY INFORMATION
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T
Risk Phrases:
R 20/22 Harmful by inhalation and if swallowed.
R 33 Danger of cumulative effects.
R 61 May cause harm to the unborn child.
R 62 Possible risk of impaired fertility.
Safety Phrases:
S 53 Avoid exposure - obtain special instructions
before use.
S 13 Keep away from food, drink and animal feeding
stuffs.
S 20/21 When using do not eat, drink or smoke.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 10099-74-8: 2
United Kingdom Occupational Exposure Limits
Canada
CAS# 10099-74-8 is listed on Canadas DSL List.
CAS# 10099-74-8 is listed on Canadas Ingredient Disclosure List.
Exposure Limits
CAS# 10099-74-8: OEL-ARAB Republic of Egypt:TWA 0.05 mg(Pb)/m3
OEL-AUSTRALIA:TWA 0.15 mg(Pb)/m3
OEL-AUSTRIA:TWA 0.1 mg(Pb)/m3
OEL-BELGIUM:TWA 0.15 mg(Pb)/m3
OEL-DENMARK:TWA 0.1 mg(Pb)/m3
OEL-FINLAND:TWA 0.1 mg(Pb)/m3
OEL-FRANCE:TWA 0.15 mg(Pb)/m3
OEL-GERMANY:TWA 0.1 mg(Pb)/m3
OEL-HUNGARY:STEL 0.04 mg(Pb)/m3;Carcinogen
OEL-THE PHILIPPINES:TWA 0.15 mg(Pb)/m3
OEL-RUSSIA:STEL 0.005 ppm (0.01 mg(Pb)/m3)
OEL-SWEDEN:TWA 0.05 mg(Pb)/m3 (resp. dust)
OEL-SWEDEN:TWA 0.1 mg(Pb)/m3 (total dust)
OEL-SWITZERLAND:TWA 0.1 mg(Pb)/m3
OEL-THAILAND:TWA 0.2 mg(Pb)/m3
OEL-TURKEY:TWA 0.2 mg(Pb)/m3
OEL-UNITED KINGDOM:TWA 0.15 mg(Pb)/m3
OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV
OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGI TLV
US FEDERAL
TSCA
CAS# 10099-74-8 is listed on the TSCA inventory.
